US Patent 12005081 Chimeric receptors and methods of use thereof

Is a

Patent

Patent attributes

Patent Applicant

Senti Biosciences

Current Assignee

Senti Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120050810

Patent Inventor Names

Jennifer Chien0

Kathryn Armstrong Loving0

Russell Morrison Gordley0

Brian Scott Garrison0

Michelle Elizabeth Hung0

Date of Patent

June 11, 2024

Patent Application Number

173385280

Date Filed

June 3, 2021

Patent Citations

‌

US Patent 7446190 Nucleic acids encoding chimeric T cell receptors

‌

US Patent 7022500 Humanized immunoglobulins

‌

US Patent 7183385 Phospho-specific antibodies to Flt3 and uses thereof

‌

US Patent 7304149 BTLA nucleic acids

‌

US Patent 10172885 Cell

‌

US Patent 10172886 Cell

‌

US Patent 10426797 Compositions and methods for treating cancer with anti-CD33 immunotherapy

‌

US Patent 10428305 Modified natural killer cells that express IL15 and uses thereof

...

Patent Primary Examiner

‌

Maria Marvich

Patent abstract

Provided herein are acute myeloid leukemia antigen targets for chimeric receptors and methods of using same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12005081 Chimeric receptors and methods of use thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12005081 Chimeric receptors and methods of use thereof